Integrative multi-omics analysis identifies genetically supported druggable targets for inflammatory bowel disease.

J Genet Eng Biotechnol · 2025 · PMC12630358 · PMID 41386873

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

marginal significanceno p-value reported

After removing associations with a P-value for HEIDI < 0.01, a total of 202 CpG sites demonstrated marginal significance (P for SMR < 0.05) in estimating the association between druggable gene methylation and IBD prevalence (Supplementary table 2).

also in 5,069 other papers

nominally significantno p-value reported

A total of 34 associations were identified at the nominally significant level (P for SMR < 0.05 and P for HEIDI > 0.01) for IBD (Supplementary table 8).

also in 7,732 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.